Cryotherapy versus Salicylic Acid with Monochloracetic Acid for the Treatment of Verrucae: A Randomised Controlled Trial
ISRCTN | ISRCTN78267267 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN78267267 |
Secondary identifying numbers | N0530132857 |
- Submission date
- 30/09/2004
- Registration date
- 30/09/2004
- Last edited
- 27/09/2011
- Recruitment status
- Stopped
- Overall study status
- Stopped
- Condition category
- Skin and Connective Tissue Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Miss Julie C Day
Scientific
Scientific
Podiatry Department
First Floor East Wing
St Pancras Hospital
4 St Pancras Way
London
NW1 0PE
United Kingdom
Phone | +44 (0)20 7530 3871 |
---|---|
jules.day@virgin.net |
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Not specified |
Study type | Not Specified |
Scientific title | |
Study objectives | Verrucae, or warts, are a common, infectious and sometimes painful problem, but it is uncertain which is the most effective treatment. We plan to compare two commonly used treatments for warts: salicylic acid with monochloracetic acid or cryotherapy. We are interested to know how effective the two treatments are in cleaning up the warts and also how cost effective the two treatments are compared to one another. Patients will also be asked about acceptability with their treatment and possible side effects such as pain. |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Skin and Connective Tissue Diseases: Warts |
Intervention | Database analysis, Questionnaires, Randomised Controlled Trial - to compare: 1. Cryotherapy 2. Salicylic acid with monochloracetic acid For treatment of plantar warts August 2008: Trial stopped 2006. |
Intervention type | Drug |
Pharmaceutical study type(s) | |
Phase | Not Specified |
Drug / device / biological / vaccine name(s) | Salicylic Acid with Monochloracetic Acid |
Primary outcome measure | A recent systematic review has highlighted the uncertainty with respect to the optimal treatment of verrucae and warts (Gibbs Set et al, BMJ, 2002). Freezing warts using cryotherapy is widespread but there is little evidence showing it is effective. However, it may be relatively cost effective compared with chemical treatments in that fewer visits may be required to eradicate the condition. There is a need for a randomised controlled trial with a cost effectiveness analysis to ascertain which is the best approach. The evidence base would aid clinical decision makers and also health care managers in resource allocation |
Secondary outcome measures | Not provided at time of registration |
Overall study start date | 29/10/2003 |
Completion date | 31/08/2004 |
Reason abandoned (if study stopped) | Problems with staffing. |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Not Specified |
Sex | Not Specified |
Target number of participants | 133 in each treatment group |
Key inclusion criteria | Not provided at time of registration |
Key exclusion criteria | Not provided at time of registration |
Date of first enrolment | 29/10/2003 |
Date of final enrolment | 31/08/2004 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Podiatry Department
London
NW1 0PE
United Kingdom
NW1 0PE
United Kingdom
Sponsor information
Department of Health
Government
Government
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
Website | http://www.dh.gov.uk/Home/fs/en |
---|
Funders
Funder type
Research organisation
North Central London Research Consortium (UK)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |